KKTV Interview – We are Losing the War on Cancer
For years doctors have been waging a fierce public battle against cancer, as most of us know, and for years one man has been studying what may be a more significant battle, behind the scenes...
History, Economics & Politics
Home >
A Raid on a Natural Medicine Clinic in the Philippines
In August 2018, 50 armed agents of the Filipino Food and Drug Administration (FDA) raided a natural medicine clinic that was treating cancer in Victoria, Tarlac. The clinic had operated...
Early Detection and Policy
Von Eschenbach's Challenge In 2006, The Bush Administration announced its intention of cutting a program that provides free breast and cervical cancer screening for low-income, working...
Dr. Farrah – Battle of the Philippines: CAM Under Attack
The complementary and alternative medicine (CAM) approach to cancer is under severe attack in the Republic of the Philippines, an island nation of 107 million people. The target? Dr. Farrah. In...
In God We Trust, All Others Show Data
A Reply to the NCI director's "Challenge Vision"--Part 2 Predictions of Cure In a 2004 article, Dr. Andrew C. von Eschenbach, the director of the US National Cancer Institute (NCI) boldly...
Oncologists Are Paid to Prescribe Dubious Drugs
“That any sane nation would give a surgeon a financial interest in cutting off your leg, is enough to make one despair of humanity. But that is precisely what we have done. And the more appalling...
The Precision Medicine Initiative
President Barack Obama In his 2015 State of the Union address, President Barack Obama launched the Precision Medicine Initiative. He stated at the time: “Doctors have always recognized that every...
Company Kills Negative Clinical Trial
Genentech, Inc. Halts a Phase III Clinical Trial In late June 2006, the pharmaceutical company Genentech, Inc. abruptly halted a large phase III clinical trial of its drug, Avastin. This trial...
National Cancer Institute in Trouble
Andrew von Eschenbach, MD The game around the National Cancer Institute (NCI) in 2006 was to guess how long it would take the acting director, John Niederhuber, MD, to remove some of the...
KFC and Cancer: What the Cluck?
Susan G. Komen for the Cure®Just a few years ago, we were told that in order to combat breast cancer we should buy a bucket of Kentucky Fried Chicken®. At the time, the sprawling chicken purveyor...
Brief History of Blocking Factors
Rigdon Lentz’s Predecessors “Overcoming suppressive activity is a prerequisite for effective immunotherapy of any sort. ” —R.D. Thornes, Lancet, 1978 (69) The concept of “blocking factors” in...
FDA and FBI Raid Oklahoma Laetrile Clinic
The Camelot ClinicOn Tuesday, April 23, 2013, agents of the Food and Drug Administration (FDA), the Federal Bureau of Investigation (FBI), and the Oklahoma Medical Board raided an alternative...
The Lancet Debate
Questioning Radiation In late March 2002, Lancet published my letter criticizing an article advocating the use of radiation as a treatment for rectal cancer. (Moss RW. Preoperative and...
Losing the War on Cancer – Fortune Magazine
“Why We're Losing the War on Cancer” An article of extraordinary importance has appeared in Fortune magazine. It is titled "Why We're Losing the War on Cancer." The author, Clifton Leaf, is...
National Cancer Institute Press Release Distorts Results on Raloxifene
Evista vs Tamoxifen Tamoxifen (sold in the US as Nolvadex®) is a useful drug. It can reduce the chance of developing breast cancer in women who are at high risk of that disease and can...
Cluck for the Cure – KFC, Acrylamide and Pinkwashing
Recently we learned that in order to fight cancer, we should buy a bucket of Kentucky Fried Chicken. This spring, the sprawling poultry purveyor and Susan G. Komen for the Cure teamed up...
Letter to the Lancet, March 10, 2001
To see the original article, click here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)71228-9/fulltext Sir—Your call in your editorial for a critical engagement with...
Exporting Cancer, American Style
I saw this scene with my own eyes in Budapest in 1991. The American “invasion” of Hungary. An international committee has established that there are now 17.2 million cancer cases and 8.9 million...
CAM Makes Progress Around the Country
Nonconventional Treatments Some time ago, professional opponents of CAM tried to use California as a beachhead from which to launch a nationwide assault on nonconventional cancer treatments....
‘Arms Race’ Grips War on Cancer: Cornell and Sloan Ready for Battle
Weill Cornell Medical College/New York-Presbyterian Hospital built a $650 million research tower to process genetic information about patients. Memorial Sloan-Kettering Cancer Center, across the...
Expanding Medical Horizons- A Report to The NIH on Alternative Medicine
A Report to the National Institutes of Health on Alternative Medical Systems and Practices in the United States Pharmacological and Biological Treatments PANEL MEMBERS Ralph W. Moss, Ph.D. --...
Down Goes Dr. Baselga
Sandpiper Trial On Saturday, June 2, 2018, Dr. José Baselga, MD, Physician-in-chief of Memorial Sloan-Kettering Cancer Center was enthused about the results of the SANDPIPER trial. He told the...
The Amazing Case of Dr Wortman
Precision Medicine Let's start with Precision Medicine at its very best. This was the inspiring story of Dr. Lukas Wortman, MD, which helped catapult the topic into public consciousness. In 2012,...
The Disturbing Case of José Baselga
Conflict of InterestThe best-publicized case of conflict of interest in cancer involved José Baselga, MD, Ph.D., the Physician-in-Chief, i.e., the top doctor of Memorial Sloan-Kettering Cancer...
cancercure.org Lawsuit
Unmasking a "Cure" On Wednesday, December 28, 2005, the US Attorney's Office in Miami, Florida, along with the Food and Drug Administration (FDA), filed a lawsuit in US District Court for...
Terminally Ill Patients Are Not Guinea Pigs
New Scientist Article In 2006, the US Court of Appeals for the District of Columbia made a decision of huge consequence. It ruled that terminally ill cancer patients have a constitutional right...
Now, Whales are Dying of Cancer
A Colony of Beluga WhalesThere is a colony of beluga whales in the upper St. Lawrence River that do not migrate but patrol a stretch of the waterway where there is abundant plankton. "They have...
How are Things in Vanuatu?
How Are Things in Vanuatu? One of my readers asked me to look into a new website, www.cancer.vu (now defunct). It was offering a remedy for cancer, she said, which appealed to her. What I found...
Nexavar Also Approved
The Fast Track In July 2007, the European Commission (EC) approved the drug Nexavar (sorafenib, formerly known as BAY 43-9006) for the treatment of advanced kidney cancer. Nexavar is classified...
Is the War on Cancer Futile?
35th Anniversary of the National Cancer Act NEXT week marks the 35th anniversary of the National Cancer Act, the opening salvo in the US government’s battle to eradicate cancer. In those 35...
ImClone’s Troubles
Two Billion Dollar Molecule In July 2002, the drug cetuximab (Erbitux®) was featured on the cover of Business Week. The New York Times called it the "two billion dollar molecule." Wall Street...
Cancer Death Rate Drama 2003-2004
The U.S. cancer death rate declined by one-half of one percent between 2003 and 2004…and the world went wild. In fact, on January 17, 2007, President Bush paid a rare visit to the National...
The Tightening Grip of Big Pharma
The “Right” to Censor Results “The Tightening Grip of Big Pharma”—no, it's not a new pamphlet from the National Health Federation, but the April 14, 2001 editorial in the august Lancet, the...
Cancer on the Decline: Playing with Numbers
If you listened to the mainstream media in February 2006, you might have thought that the end of cancer was finally in sight. The cancer death rates were down for the first time in over 70 years....
FDA approves Gemzar for Ovarian Cancer
Despite its Lack of Efficacy The Food and Drug Administration (FDA) took the rare step of overruling one of its own advisory panels and approved the drug Gemzar (known generically as gemcitabine)...
Patents Over Patients by Ralph W. Moss, PhD – New York Times op-ed
For the first time, I have had an op-ed piece published in the Sunday New York Times. (It can be viewed at: https://www.nytimes.com/2007/04/01/opinion/01moss.html.) [pda_pdf_viewer id=539282...